Acceptted version_Vahdatpour_et_al-2019-Journal_of_Diabetes_Investigation.pdf (894.45 kB)
Leucine-glycine and carnosine dipeptides prevent diabetes induced by multiple low-dose streptozotocin in experimental model of adult mice
journal contribution
posted on 2023-06-09, 16:51 authored by Tohid Vahdatpour, Ali Nokhodchi, Parvin Zakeri-Milani, Mehran Mesgari-Abbasi, Naser Ahmadi-Asl, Hadi ValizadehAims/Introduction Peptides are considered as quasi-hormones and effective molecules for regulation of the cells function and metabolic disorders prevention. Di- and tripeptides with the ability to gastrointestinal absorption have been proposed to prevent diabetes progression. Materials and Methods Small peptides with different sequences of specific amino acids were synthesized based on a solid phase peptide synthesis (SPPS) protocol as well as carnosine (A) and glutathione (B) were examined for the prevention of diabetes induced by multiple low-dose of streptozotocin (MLDS) in mice. Results The peptides A, Leu-Gly (D) and Pro-Pro (F) exhibited a preventive effects on blood glucose elevation and impairment of the signaling and performance of beta cells. The beta cells function assessed by immunofluorescence and blood glucose level in mice exposed to diabetes treated by the peptides A and D was similar to the normal mice. The peptide D prevented from body weight loss caused by diabetes induction. The use of D and A peptides dramatically prevents the incidence of disruption in beta cells signaling by maintaining the natural balance of intracellular Akt-2 and cAMP. Conclusions The results proved that peptide D (Leu-Gly) named Hannaneh inhibits the body weight loss caused by diabetes induction. The Hannaneh and carnosine dipeptides with preservation of normal beta cell signalling and anti DPP-4 activity were prevented from increasing the blood glucose in mice at risk of diabetes. These dipeptides may be regarded as the pharmaceutical agents for the prevention of diabetes.
History
Publication status
- Published
File Version
- Accepted version
Journal
Journal of Diabetes InvestigationISSN
2040-1116Publisher
WileyExternal DOI
Department affiliated with
- Chemistry Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2019-02-13First Open Access (FOA) Date
2019-02-13First Compliant Deposit (FCD) Date
2019-02-12Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC